Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways
Field | Value | Language |
dc.contributor.author | Preston, E | |
dc.contributor.author | Cooney, JG | |
dc.contributor.author | Wilks, D | |
dc.contributor.author | Baran, K | |
dc.contributor.author | Zhang, L | |
dc.contributor.author | Kraegen, EW | |
dc.contributor.author | Sainsbury, Amanda | |
dc.date.accessioned | 2017-01-23 | |
dc.date.available | 2017-01-23 | |
dc.date.issued | 2011-12-01 | |
dc.identifier.uri | http://hdl.handle.net/2123/16219 | |
dc.publisher | Neuropeptides | en_AU |
dc.subject | Neuropeptide Y | en_AU |
dc.subject | Melanocortin 4 antagonism | en_AU |
dc.subject | Free T4 | en_AU |
dc.subject | Thyroid stimulating hormone | en_AU |
dc.subject | Intracerebroventricular administration | en_AU |
dc.subject | Corticosterone | en_AU |
dc.title | Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1016/j.npep.2011.07.009 | |
dc.type.pubtype | Post-print | en_AU |
Associated file/s
Associated collections